Neurology Diagnostics Articles & Analysis
14 news found
Medical science is witnessing remarkable advancements in neurology and oncology, with cutting-edge technologies shaping the future of patient care. Transcranial techniques are improving neurological diagnostics, while tumor tissue-based technology is revolutionizing cancer treatment, particularly in prostate cancer screening. ...
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that management will be presenting at the upcoming conferences: BioFuture Panel Title: New Diagnostics: Revolutionizing Care in ...
The miniseries was created with support from Altoida, a leading platform to improve drug development, research, and care for patients with neurological diseases including Alzheimer's. The launch coincides with the observation of Alzheimer's and Brain Awareness Month, and follows the successful pilot of the first Health Unmuted miniseries, COPD Podcast. ...
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced the appointment of Dr. ...
Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that it has successfully raised an additional $14 million for its Series A round with new and existing investors. ...
Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics, announced today a partnership with Click Therapeutics, a leader in Digital Therapeutics™ as prescription medical treatments, to bring more sensitive measures of cognition into their digital therapeutics research. ...
Altoida, Inc. an AI company pioneering next-generation neurological disease diagnostics, and GN Group, a global leader in intelligent audio solutions, have signed a multi-year strategic partnership to research and develop new digital biomarkers for identifying Mild Cognitive Impairment (MCI). ...
CB Insights today named Altoida, Inc. an AI company pioneering next-generation neurological disease diagnostics, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. ...
These features help make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. About C2N Diagnostics, LLC C2N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent ...
These features make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. ...
C2N Diagnostics, which offers the PrecivityAD™ blood test that can help detect if certain markers for Alzheimer’s disease are in the brain, now has its analytical validation results available for review. ...
We know there’s an urgent need for non-invasive and easily available diagnostic tools that identify Alzheimer’s pathology,” says Dr. ...
These features make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. ...
A breakthrough in Alzheimer’s disease has arrived with the introduction of C2N Diagnostics’ PrecivityAD™ blood test into the clinic. Researchers at C2N Diagnostics have found the PrecivityAD™ test predicts Alzheimer’s brain pathology in people with memory and thinking issues. ...